Company intelligence / Profile preview
NanoNeurosciences
Alachua / Gainesville area*, Florida, United Statesnanoneurosciences.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NanoNeurosciences is developing a nanotechnology-based platform using self-organizing lipopeptide sequences to deliver neuroactive molecules in a controlled and sustained manner. Their lead program targets primary open-angle glaucoma and other degenerative eye diseases. The company is currently at the pre-clinical stage; no published clinical results are available yet.[1][2][3]
- Therapeutic areas
- Ophthalmology
- Modalities
- LipopeptidesNanostructures for drug deliveryNeuropeptidesmRNA delivery systems[1][2][3]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
UF Innovate | Sid Martin Biotech Accelerator client company affiliation/partnerships with University of Florida innovation ecosystem[4]
Beyond the preview
Go deeper on NanoNeurosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NanoNeurosciences.